0GQU Stock Overview
Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products Sweden.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Active Biotech AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr1.01 |
52 Week High | kr1.25 |
52 Week Low | kr1.01 |
Beta | 0.53 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | -66.10% |
Change since IPO | -98.35% |
Recent News & Updates
Recent updates
Shareholder Returns
0GQU | GB Biotechs | GB Market | |
---|---|---|---|
7D | 0% | -0.9% | -0.01% |
1Y | n/a | -29.6% | 0.8% |
Rentabilidad frente al sector: Datos insuficientes para determinar los resultados de 0GQU en comparación con el sector UK Biotechs .
Rentabilidad vs. Mercado: Datos insuficientes para determinar el rendimiento de 0GQU frente al mercado UK.
Price Volatility
0GQU volatility | |
---|---|
0GQU Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 7.2% |
Market Average Movement | 4.9% |
10% most volatile stocks in GB Market | 11.4% |
10% least volatile stocks in GB Market | 2.6% |
Precio estable de las acciones: 0GQU no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de 0GQU en el último año.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 9 | Helen Tuvesson | https://www.activebiotech.com |
Active Biotech AB (publ) Fundamentals Summary
0GQU fundamental statistics | |
---|---|
Market cap | kr250.32m |
Earnings (TTM) | -kr58.40m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-4.3x
P/E RatioIs 0GQU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0GQU income statement (TTM) | |
---|---|
Revenue | kr0 |
Cost of Revenue | kr0 |
Gross Profit | kr0 |
Other Expenses | kr58.40m |
Earnings | -kr58.40m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
May 04, 2023
Earnings per share (EPS) | -0.22 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did 0GQU perform over the long term?
See historical performance and comparison